Strata Critical Medical (SRTA) Stock Price, News & Analysis

Company Overview

Blade Air Mobility, Inc. provides air transportation alternatives to the congested ground routes in the United States. It provides its services through charter and by-the-seat flights using helicopters, jets, turboprops, and amphibious seaplanes. The company was founded in 2014 and is headquartered in New York, New York.

Key Stats

• Today's Range: $5.61 to $5.78
• 50-Day Range: $4.28 to $6.05
• 52-Week Range: $3.95 to $6.50
• Volume: 309,857 shs
• Average Volume: 975,334 shs
• Market Capitalization: $499.41 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $8.00
• Consensus Rating: Moderate Buy

Strata Critical Medical Stock Analysis - MarketRank™

Strata Critical Medical scored higher than 54% of companies evaluated by MarketBeat, and ranked 489th out of 892 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.6 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Strata Critical Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 1 strong buy rating, 1 buy rating, 2 hold ratings, and no sell ratings.

Upside Potential

Strata Critical Medical has a consensus price target of $8.00, representing about 40.7% upside from its current price of $5.69.

Amount of Analyst Coverage

Strata Critical Medical has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Strata Critical Medical are expected to grow in the coming year, from ($0.12) to $0.09 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Strata Critical Medical is -190.17, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Strata Critical Medical is -190.17, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Strata Critical Medical has a P/B Ratio of 1.82. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

6.09% of the float of Strata Critical Medical has been sold short.

Short Interest Ratio / Days to Cover

Strata Critical Medical has a short interest ratio ("days to cover") of 4.98.

Change versus previous month

Short interest in Strata Critical Medical has recently increased by 0.27%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Strata Critical Medical does not currently pay a dividend.

Dividend Growth

Strata Critical Medical does not have a long track record of dividend growth.

News and Social Media

• Score: 2.2 / 5
• News Sentiment: 0.55

News Sentiment

Strata Critical Medical has a news sentiment score of 0.55. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 5 news articles for Strata Critical Medical this week, compared to 2 articles on an average week.

MarketBeat Follows

Only 1 people have added Strata Critical Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 3.3 / 5
• Insider Trading: Acquiring Shares

Net Insider Buying

Over the last three months, insiders have purchased a net $10,000.00 in company stock, which represents 0.0020% of the company's market cap.

Insider Buying vs. Insider Selling

In the past three months, Strata Critical Medical insiders have bought more of their company's stock than they have sold. Specifically, they have bought $10,000.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

15.50% of the stock of Strata Critical Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

47.36% of the stock of Strata Critical Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 11/03/2026
• Today: 11/13/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Healthcare Services
• Current Symbol: NASDAQ:SRTA
• CIK: 1779128
• Web: www.stratacritical.com
• Phone: (212) 967-1009
• Fax: N/A
• Employees: 601
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Strata Critical Medical: $8.00
• High Price Target: $8.00
• Low Price Target: $8.00
• Potential Upside/Downside: +40.7%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.75
• Research Coverage: 4 Analysts

Profitability

• EPS (Trailing Twelve Months): ($0.03)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 63.18
• P/E Growth: N/A
• Net Income: $41.35 million
• Net Margins: -8.84%
• Pretax Margin: -7.52%
• Return on Equity: -2.71%
• Return on Assets: -2.31%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 2.77
• Quick Ratio: 2.77

Sales & Book Value

• Annual Sales: $197.14 million
• Price / Sales: 2.55
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $3.12 per share
• Price / Book: 1.82

Miscellaneous

• Outstanding Shares: 88,470,000
• Free Float: 74,755,000
• Market Cap: $503.04 million
• Optionable: Optionable
• Beta: 2.56